File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Genetic mapping for thyrotoxic periodic paralysis

TitleGenetic mapping for thyrotoxic periodic paralysis
Authors
Issue Date2001
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/
Citation
The 2nd International Huaxia Congress of Endocrinology (IHCE), Hong Kong, 14-17 December 2001. In Hong Kong Medical Journal, 2001, v. 7 n. 4 suppl. 2, p. 122, abstract no. P99 How to Cite?
AbstractTPP is a complication of thyrotoxicosis affecting 25% of thyrotoxic southern Chinese male but not female patients. Paralysis due to hypokalemia typically occurs after a high carbohydrate meal. This episodic paralysis will remit with the control of thyrotoxicosis but may recur with relapse of the disease. Shifting of potassium into intracellular space results in hypokalemia and paralysis. Increased Na, K-ATPase activity has been observed in TPP patients when compared to thyrotoxic Graves’ disease (GD) patients and normal controls. To study the association of Na, K-ATPase genotype with TPP, we evaluated TPP patients (n = 100) and compared them to male GD patients without TPP (n = 60) and normal male subjects (n = 70). A set of polymorphic microsatellite markers with a genetic distance < 10 cM was used to study the allelic distribution. Our results showed that there was no significant difference between the 3 groups in the allelic distribution for all markers associated with the Na, K-ATPase α1 (1p13), α2 (1q21-23), α3 (19q13.2) and β1 (1q22-25), β2 (17p13.1), β3 (3q22-23) genes. There was also no association of CACNL1A3 (dihydropyridine sensitive calcium channel receptor gene, located at chromosome 1q32) with TPP. Mutation of CACNL1A3 gene is linked to Familial Hypokalemia Periodic Paralysis in Caucasians. On screening the X-chromosome, one of the alleles (size 289) of the marker DXS1214 in the region of Xp11.3-21 was observed to be more frequent in TPP subjects when compared to GD patients and normal subjects (p < 0.05), suggesting that this locus may be linked to TPP.
DescriptionSymposium on Endocrine Surgery
Persistent Identifierhttp://hdl.handle.net/10722/102800
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorLau, KS-
dc.contributor.authorChan, VNY-
dc.contributor.authorKung, AWC-
dc.date.accessioned2010-09-25T20:45:20Z-
dc.date.available2010-09-25T20:45:20Z-
dc.date.issued2001-
dc.identifier.citationThe 2nd International Huaxia Congress of Endocrinology (IHCE), Hong Kong, 14-17 December 2001. In Hong Kong Medical Journal, 2001, v. 7 n. 4 suppl. 2, p. 122, abstract no. P99-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/102800-
dc.descriptionSymposium on Endocrine Surgery-
dc.description.abstractTPP is a complication of thyrotoxicosis affecting 25% of thyrotoxic southern Chinese male but not female patients. Paralysis due to hypokalemia typically occurs after a high carbohydrate meal. This episodic paralysis will remit with the control of thyrotoxicosis but may recur with relapse of the disease. Shifting of potassium into intracellular space results in hypokalemia and paralysis. Increased Na, K-ATPase activity has been observed in TPP patients when compared to thyrotoxic Graves’ disease (GD) patients and normal controls. To study the association of Na, K-ATPase genotype with TPP, we evaluated TPP patients (n = 100) and compared them to male GD patients without TPP (n = 60) and normal male subjects (n = 70). A set of polymorphic microsatellite markers with a genetic distance < 10 cM was used to study the allelic distribution. Our results showed that there was no significant difference between the 3 groups in the allelic distribution for all markers associated with the Na, K-ATPase α1 (1p13), α2 (1q21-23), α3 (19q13.2) and β1 (1q22-25), β2 (17p13.1), β3 (3q22-23) genes. There was also no association of CACNL1A3 (dihydropyridine sensitive calcium channel receptor gene, located at chromosome 1q32) with TPP. Mutation of CACNL1A3 gene is linked to Familial Hypokalemia Periodic Paralysis in Caucasians. On screening the X-chromosome, one of the alleles (size 289) of the marker DXS1214 in the region of Xp11.3-21 was observed to be more frequent in TPP subjects when compared to GD patients and normal subjects (p < 0.05), suggesting that this locus may be linked to TPP.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleGenetic mapping for thyrotoxic periodic paralysis-
dc.typeConference_Paper-
dc.identifier.emailLau, KS: kslau@hkucc.hku.hk-
dc.identifier.emailChan, VNY: vnychana@hku.hk-
dc.identifier.emailKung, AWC: awckung@hku.hk-
dc.identifier.authorityChan, VNY=rp00320-
dc.identifier.authorityKung, AWC=rp00368-
dc.description.naturepublished_or_final_version-
dc.identifier.hkuros65321-
dc.identifier.volume7-
dc.identifier.issue4 suppl. 2-
dc.identifier.spage122, abstract no. P99-
dc.identifier.epage122, abstract no. P99-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats